Yumanity Therapeutics' Series A Round

Yumanity Therapeutics raised a round of funding on February 10, 2016.

Yumanity Therapeutics specializes in drug discovery for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies for patients with Alzhei…

Articles about Yumanity Therapeutics' Series A Round: